Results 11 to 20 of about 3,750,451 (195)
Antiplatelet agents: an overview
Journal of the Arab Society for Medical Research, 2023 Platelets play a major role in normal hemostatic and thrombotic processes. Aggregation of platelets presents the key pathophysiological step in the development of cardiovascular diseases; hence, antiplatelet agents remain crucial in the treatment of ...
Asma Haffouz +2 more
doaj +2 more sources
Efficacy and Safety of Antiplatelet Agents for Adult Patients With Ischemic Moyamoya Disease
Frontiers in Neurology, 2021 Background: The use of antiplatelet agents in ischemic moyamoya disease (MMD) is controversial. This study aimed to investigate the effectiveness and safety of antiplatelet therapy compared with conservative treatment and surgical revascularization in ...
Fei Ye +12 more
semanticscholar +1 more source
Antiplatelet therapy in stroke prevention after non-cardioembolic transient ischemic attack
Неврология, нейропсихиатрия, психосоматика, 2021 The review shows modern concepts on the role of antiplatelet therapy in the secondary prevention of cardiovascular diseases in patients after non-cardioembolic ischemic stroke or transient ischemic attack (TIA). We present an analytical characteristic of
A. V. Fonyakin +2 more
doaj +1 more source
Perioperative Guidelines on Antiplatelet and Anticoagulant Agents: 2022 Update
Current Anesthesiology Reports, 2022 Purpose of Review Multiple guidelines and recommendations have been written to address the perioperative management of antiplatelet and anticoagulant drugs.
M. Moster, D. Bolliger
semanticscholar +1 more source
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021 Background Although antiplatelet agents are frequently prescribed in moyamoya disease in routine clinical practice, there are no large‐scale epidemiologic trials or randomized trial evidence to support their use in patients with moyamoya disease. Methods
Woo‐Keun Seo +7 more
doaj +1 more source
PLoS ONE, 2021 BackgroundThe interaction between smoking and the use of antiplatelet agents on the prognosis of vasospastic angina (VA) is rarely investigated.MethodsVA-Korea is a nation-wide multi-center registry with prospective design (n = 1812).
Seong-Sik Cho +15 more
doaj +1 more source
Biomarkers for Antiplatelet Therapies in Acute Ischemic Stroke: A Clinical Review
Frontiers in Neurology, 2021 Stroke is one of the world's leading causes of disability and death. Antiplatelet agents are administered to acute ischemic stroke patients as secondary prevention.
Adel Alhazzani +6 more
doaj +1 more source
Novel Antiplatelet Agents in Cardiovascular Disease
Journal of Cardiovascular Pharmacology and Therapeutics, 2020 Antiplatelet therapy reduces atherothrombotic risk and has therefore become a cornerstone in the treatment of cardiovascular disease. Aspirin, adenosine diphosphate P2Y12 receptor antagonists, glycoprotein IIb/IIIa inhibitors, and the thrombin receptor ...
M. Tscharre +2 more
semanticscholar +1 more source
NEW ANTIPLATELET DRUGS (PART 1)
Рациональная фармакотерапия в кардиологии, 2016 Antiplatelet agents are a necessary component of modern atherosclerosis therapy. The difficulties of antiplatelet treatment lie in the balance between the necessary therapeutic effect of the drug and the risk of excessive action leading to the bleeding ...
A. B. Sumarokov
doaj +3 more sources
Scientific Reports, 2020 For the first time, a series of highly potent natural product inspired substituted (Z)-3-benzylideneisobenzofuran-1(3H)-ones 28a-t, embraced with electron-withdrawing groups (EWG) and electron-donating groups (EDG) at site I and site II, were prepared ...
Bharti Rajesh Kumar Shyamlal +7 more
semanticscholar +1 more source